FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

EUA for Modified Administration of Monkeypox Vaccine

FDA issues Bavarian Nordic an emergency use authorization for its smallpox/monkeypox vaccine Jynneos to allow healthcare providers to use administer i...

latest-news-card-1
Marketing

Understanding Drug Risks and Benefits in Tweets

CDER advertising researchers say their study of character-space-limited communications like Tweets in terms of drug benefit and risk information has i...

Human Drugs

Amazon Distributing Unapproved New Drugs: FDA

FDA warns Amazon.com that its fulfillment service is distributing unapproved new drugs sold over-the-counter as mole and skin tag removers.

latest-news-card-1
Human Drugs

FDA Extends Review of Reata Pharma NDA

FDA extends by three months the review of a Reata Pharmaceuticals NDA for omaveloxolone to allow time to evaluate additional data just submitted to th...

Federal Register

Allergenic Products Advisory Panel Renewed

Federal Register notice: FDA renews its Allergenic Products Advisory Committee for an additional two years beyond the charter expiration date.

latest-news-card-1
Federal Register

50 NDAs Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that 50 listed drug products were not withdrawn for safety or effectiveness reasons.

latest-news-card-1
Human Drugs

Appeals Court Affirms Dismissal of FOIA Case

The 2nd Circuit Court of Appeals says a New York federal court properly granted summary judgment to FDA and Sarepta in a Freedom of Information Act ca...

latest-news-card-1
Medical Devices

FDA Says Haimen Shengbang Container Recall Class 1

FDA says the Haimen Shengbang Laboratory Equipment recall of unapproved viral transport media containers is Class 1.

latest-news-card-1
Human Drugs

European Data Privacy Law Affects FDA: Attorney

FDA attorney Heather Messick describes agency concerns with the European Union's General Data Protection Regulation.

latest-news-card-1
Federal Register

Info Collection on Device Q-Submissions

Federal Register notice: FDA seeks comments on an information collection revision entitled "Q-Submissions Program for Medical Devices."